Tvardi Therapeutics Statistics
Total Valuation
TVRD has a market cap or net worth of $309.46 million. The enterprise value is $267.21 million.
Important Dates
The last earnings date was Thursday, August 14, 2025, before market open.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TVRD has 9.38 million shares outstanding. The number of shares has increased by 22.68% in one year.
Current Share Class | 9.38M |
Shares Outstanding | 9.38M |
Shares Change (YoY) | +22.68% |
Shares Change (QoQ) | +32.09% |
Owned by Insiders (%) | 8.81% |
Owned by Institutions (%) | 26.38% |
Float | 7.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 9.35 |
P/TBV Ratio | 9.45 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.01.
Current Ratio | 4.04 |
Quick Ratio | 3.84 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -89.81% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.97M |
Employee Count | 12 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +194.27% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +194.27% |
50-Day Moving Average | 26.17 |
200-Day Moving Average | 20.03 |
Relative Strength Index (RSI) | 67.89 |
Average Volume (20 Days) | 20,067 |
Short Selling Information
The latest short interest is 660,592, so 7.04% of the outstanding shares have been sold short.
Short Interest | 660,592 |
Short Previous Month | 594,235 |
Short % of Shares Out | 7.04% |
Short % of Float | 8.49% |
Short Ratio (days to cover) | 0.26 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -29.70M |
Pretax Income | n/a |
Net Income | -23.63M |
EBITDA | -29.61M |
EBIT | -29.70M |
Earnings Per Share (EPS) | -$3.94 |
Full Income Statement Balance Sheet
The company has $40.99 million in cash and $254,000 in debt, giving a net cash position of $40.74 million or $4.34 per share.
Cash & Cash Equivalents | 40.99M |
Total Debt | 254,000 |
Net Cash | 40.74M |
Net Cash Per Share | $4.34 |
Equity (Book Value) | 32.93M |
Book Value Per Share | 3.51 |
Working Capital | 32.45M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -25.05M |
Capital Expenditures | n/a |
Free Cash Flow | -25.05M |
FCF Per Share | -$2.67 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TVRD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.68% |
Shareholder Yield | -22.68% |
Earnings Yield | -7.67% |
FCF Yield | -8.13% |
Analyst Forecast
The average price target for TVRD is $59.20, which is 79.39% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $59.20 |
Price Target Difference | 79.39% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |